Companies · Other Health Care

Magnetecs Corp

INGLEWOOD · Other Health Care

Diligence memoA one-page analyst read on Magnetecs Corp — recommendation, valuation, rhythm, risks.
$19.8M
Total raised · real
7
Rounds
4.3×
Latest step-up
Top 17%
Sector rank · raised
Series A
Latest stage · inferred · Mon Aug 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Magnetecs Corp looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.73× the median modeled value of Series A Other Health Care companies in 2013–2015 (187 peers) — value vs value, same stage and era.
  • Within the normal band (73% of peer median) for its niche.
Dormant
  • Last raise 10.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Magnetecs Corp is one of 5376 Other Health Care companies tracked from INGLEWOOD. By capital raised it ranks in the upper tier (ahead of 84% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2009-12-29 Raised $2.0M (real) Modeled valuation $50M (est)Seed2009Seed · 2010-07-30 Raised $3.7M (real) Modeled valuation $92M (est)Seed2010Series A · 2010-07-30 Raised $8.0M (real) Modeled valuation $161M (est)Series A2010Series A · 2011-07-01 Raised $337K (real) Modeled valuation $6.8M (est)Series A2011Series A · 2012-06-20 Raised $320K (real) Modeled valuation $6.5M (est)Series A2012Series A · 2012-06-20 Raised $320K (real) Modeled valuation $6.5M (est)Series A2012Series A · 2014-04-10 Raised $1.0M (real) Modeled valuation $21M (est)Series A2014Series A · 2015-08-31 Raised $4.4M (real) Modeled valuation $88M (est)Series A2015+$3.7M+$8.0M+$337K+$320K+$320K+$1.0M+$4.4MCumulative $20M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.0M · 2009
Seed extension$3.7M · 2010
Series A$8.0M · 2010
Series A extension$337K · 2011
Series A extension$320K · 2012
Series A extension$320K · 2012
Series A extension$1.0M · 2014
Series A extension$4.4M · 2015

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$88.1M
Base estimate est.
$5.6M
Conservative case
$479.3M
Upside case
$19.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $50.0M · 2009-12-292009Seed · modeled $92.5M · 2010-07-30Series A · modeled $161.0M · 2010-07-30Series A · modeled $6.8M · 2011-07-01Series A · modeled $6.5M · 2012-06-20Series A · modeled $6.5M · 2012-06-20Series A · modeled $20.5M · 2014-04-10Series A · modeled $88.1M · 2015-08-312015
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
10.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
10 mo
Avg between rounds
$3.5M/yr
Capital velocity
16.5 yr
On record since
2009
First round
8
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 8.1× above median
This company$19.8M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.8× of median
This company$4.4M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 4.0× above median
This company$88.1M
Sector median$22.1M

Raised more than 84% of sector peers (real $). Modeled value above 77% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #128 of 187.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)Imagine Health, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Inova Labs, Inc. · Series A Raised $32.6M · modeled $302.7M (est)Spruce Health, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Cephea Valve Technologies, Inc. · Series A Raised $21.2M · modeled $296.8M (est)ClarVista Medical, Inc. · Series A Raised $14.5M · modeled $293.0M (est)Minimally Invasive Devices Inc. · Series A Raised $43.3M · modeled $284.9M (est)Osprey Medical Inc. · Series A Raised $14.0M · modeled $282.5M (est)IGeneX Group, LLC · Series A Raised $13.5M · modeled $273.4M (est)Urohsd, Llc · Series A Raised $13.2M · modeled $266.9M (est)Secure EDI Holdings, LLC · Series A Raised $28.3M · modeled $263.5M (est)Sterling Healthcare Holdings, Llc · Series A Raised $13.4M · modeled $259.1M (est)Wallick Senior Housing Holdings, LLC · Series A Raised $12.8M · modeled $259.1M (est)Magnetecs Corp (this company) Raised $19.8M · modeled $88.1M (est)Magnetecs Corp
CompanyStageRaised · realValue · estvs peer med.
Imagine Health, Inc.Series A$15.0M$302.7M2.50×
Inova Labs, Inc.Series A$32.6M$302.7M2.50×
Spruce Health, Inc.Series A$15.0M$302.7M2.50×
Cephea Valve Technologies, Inc.Series A$21.2M$296.8M2.46×
ClarVista Medical, Inc.Series A$14.5M$293.0M2.42×
Minimally Invasive Devices Inc.Series A$43.3M$284.9M2.36×
Osprey Medical Inc.Series A$14.0M$282.5M2.34×
IGeneX Group, LLCSeries A$13.5M$273.4M2.26×
Urohsd, LlcSeries A$13.2M$266.9M2.21×
Secure EDI Holdings, LLCSeries A$28.3M$263.5M2.18×
Sterling Healthcare Holdings, LlcSeries A$13.4M$259.1M2.14×
Wallick Senior Housing Holdings, LLCSeries A$12.8M$259.1M2.14×
Magnetecs Corp this companySeries A$19.8M$88.1M0.73×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.0M2009-12-29$10.1M$50.0M90%
Seed$3.7M2010-07-30$18.7M$92.5M90%
Series A$8.0M2010-07-30$36.3M$161.0M90%
Series A$337K2011-07-01$1.5M$6.8M90%
Series A$320K2012-06-20$1.5M$6.5M90%
Series A$320K2012-06-20$1.5M$6.5M90%
Series A$1.0M2014-04-10$4.6M$20.5M90%
Series A$4.4M2015-08-31$19.9M$88.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.0M2009-12-29
    • First recorded raise — entered as Seed.
  2. Seed$3.7M2010-07-30
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 1.8× larger than the prior — scaling up.
  3. Series A$8.0M2010-07-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× larger than the prior — scaling up.
  4. Series A$337K2011-07-01
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 23.7× smaller than the prior — bridge or down round.
  5. Series A$320K2012-06-20
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  6. Series A$320K2012-06-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  7. Series A$1.0M2014-04-10
    • Raised again after 22 mo — slower than the ~14 mo sector norm.
    • Round 3.2× larger than the prior — scaling up.
  8. Series A$4.4M2015-08-31
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 4.3× larger than the prior — scaling up.
Intelligence
2016 ~Q2
Modeled next raise · ~10mo cadence
$13.1M
Modeled next size est.range $8.5M$21.0M
4.3×
Last step-up
$3.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Eli Gang4 other2010-07
Frank Adell4 other2012-06
Josh Shachar4 other2009-12
Asher Holzer3 other2012-06
Christopher Bissell1 other2014-04
Thomas O Neil1 other2012-06
Christopher Bissel2012-06
Clive Zickel2010-07
Eli S. Gang2009-12
Eustaquio Abay2015-08
Eytan Lombroso2010-07
Eytan S. Lombroso2009-12
Faroukh Adelzadeh2010-07
Faroukh S. Adelzadeh2009-12
Geoffrey Commons2012-06
Henry Grause2012-06
Len Epstein2012-06
Leonard Epstein2015-08
Robert Madden2010-07
William S. Van Wagner2009-12
William Van Wagner2010-07
Registry & provenance

Magnetecs Corp is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1352362
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Pharmaco-Kinesis CorpOther Health CareSeries B$17.2M$30.8Mnetwork3 shared operators · same sector
Cognos Therapeutics IncBiotechnologySeries C$7.7M$44.2Mnetwork3 shared operators
Autonomous Medical Devices IncHealthtechSeries D+$142.4M$2.8Bnetwork3 shared operators
Cayenne Medical IncOther Health CareSeries A$19.8M$100.9Msame sector · same stage
Insightra Medical, Inc.Other Health CareSeries A$20.0M$100.9Msame sector · same stage
US Retina LLCOther Health CareSeries A$20.0M$101.3Msame sector · same stage
Discover Echo Inc.Other Health CareSeries A$18.6M$80.7Msame sector · same stage
Ark National Holdings LLCOther Health CareSeries A$21.0M$83.0Msame sector · same stage
Frequently asked
How much funding has Magnetecs Corp raised?
Magnetecs Corp has raised approximately $19.8M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Magnetecs Corp's estimated valuation?
Provath's modeled valuation for Magnetecs Corp is approximately $88.1M (modeled range $5.6M–$479.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Magnetecs Corp at?
Magnetecs Corp's latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Aug 31.
What does Magnetecs Corp do and where is it based?
Magnetecs Corp operates in the Other Health Care sector, based in INGLEWOOD.
Explore related

See where Magnetecs Corp sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Magnetecs Corp, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.